BCM
EDSA icon

Boxer Capital Management’s Edesa Biotech EDSA Stock Holding History

Boxer Capital Management’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
+205,000
New +$1.85M 0.13% 57

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boxer Capital Management's EDSA Position: Q2 2026 in Review

Boxer Capital Management opened a new position in Edesa Biotech (EDSA) in Q2 2026: 205,000 shares worth $1.67M. The stake represents 0.13% of the portfolio and ranks #57 among its holdings.

30 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Boxer Capital Management held 205,000 shares of Edesa Biotech worth $1.67M as of Q2 2026.
  • Edesa Biotech was a new Boxer Capital Management position in Q2 2026.
  • Edesa Biotech made up 0.13% of Boxer Capital Management's portfolio in Q2 2026, its #57 holding.
  • 30 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.